Deepa Pakianathan, PhD, is a Managing Member (also cited as Managing Partner) at Delphi Ventures. See sector focus and contact routes.
Deepa Pakianathan, PhD, is a Managing Member (also cited as Managing Partner) at Delphi Ventures, where she has served since 2001 and leads the firm’s biotechnology investment activities. Delphi Ventures focuses exclusively on biotechnology and medical device investments, and Pakianathan’s thesis centers on these sectors without explicit public mention of specific stages or geographies beyond the firm’s biotech focus. Her typical check size and whether she leads or follows on investments are not publicly documented in the available sources. Notable portfolio companies where she has held board roles include Karyopharm Therapeutics (since 2013), Mereo Biopharma Group PLC (since 2019), Theravance Biopharma (appointed July 2020), and Calithera Biosciences (since 2012). Pakianathan’s distinctive point of view stems from her PhD in immunology and prior experience as a biotech banker at JPMorgan and research scientist at Genentech, which informs her governance and investment approach in biotech. However, no public writing, articles, or distinctive quoted investment philosophy by her are found in the search results.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Mateo.
Investors like Deepa Pakianathan · Full investor directory · Investor access · Company funding database